CCND1 and dysplasia: The expression of cyclin D1 should not be detected in normal gastric mucosa, and there are significant trends (p < 0.01) for increased expression of cyclin D1 in non-neoplastic mucosa, including in conditions such as gastric atrophy, dysplasia, intestinal metaplasia, and gastritis to gastric cancer [26].